Restoration of mammillothalamic functional connectivity through thiamine replacement therapy in Wernicke's

Eosu Kim1, Jeonghun Ku, Young-Chul Jung

  • 1Department of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, 134 Shinchon-dong, 250 Seongsanno, Seodaemeun-gu, Seoul 120-752, Republic of Korea.

Neuroscience Letters
|June 22, 2010
PubMed

Insights

Resting-state fMRI shows promise in tracking memory recovery in Wernicke encephalopathy patients undergoing thiamine therapy. Connectivity changes in the mammillothalamic tract correlated with memory improvements, suggesting clinical utility.

Area of Science:

  • Neuroscience
  • Radiology
  • Clinical Neurology

Background:

  • Neuropsychiatric illnesses are increasingly studied using resting-state functional MRI (fMRI).
  • The clinical utility of fMRI in these conditions remains under investigation.
  • Wernicke encephalopathy (WE) is a neurological condition often associated with thiamine deficiency.

Observation:

  • This study presents longitudinal resting-state fMRI data from a single WE patient over 20 months.
  • Mammillothalamic functional connectivity was measured between the mammillary body and anterior thalamus.
  • Delayed verbal and nonverbal recall memory scores were assessed alongside fMRI data.

Findings:

  • Mammillothalamic functional connectivity changes mirrored memory score fluctuations in both hemispheres.
  • Left-hemisphere connectivity and verbal recall showed a strong correlation with overall clinical status.
  • Modified directed transfer function (dDTF) analysis revealed directional information flow from mammillary bodies to the thalamus, except during acute illness.

Implications:

  • Resting-state fMRI may be a valuable tool for monitoring thiamine replacement therapy effectiveness in WE patients.
  • The findings suggest fMRI can track functional recovery in memory-related neural pathways at an individual level.
  • This preliminary study highlights the potential of fMRI in personalized medicine for WE and similar conditions.